Abstract: The present invention relates to the isolation, purification and characterization of the Lipopolysaccharide (LPS) from Ochrobactrum intermedium strain LMG3306, and their use as immunostimulant of mammalians, the process for the preparation of a pharmaceutical compound for the treatment and/or prevention of the sepsis and adjuvant for a vaccine in immunosupressed animals and against Leishmania.
Type:
Grant
Filed:
December 31, 2009
Date of Patent:
January 26, 2016
Assignee:
LABORATORIOS OVEJERO, S.A.
Inventors:
Juan Ignacio Ovejero Guisasola, Manuel Fresno Escudero